V Rossii zaregistrirovan Ksalkori®(krizotinib) kak pervyy i edinstvennyypreparat dlya lecheniya ALK-pozitivnogonemelkokletochnogo raka legkogo
- Authors: - -
- Issue: Vol 14, No 4 (2012)
- Pages: 7-
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/29516
- ID: 29516
Cite item